Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post-transplant Hepatitis C”

52 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 52 results

Not applicableUnknownNCT01944527
What this trial is testing

Use of Direct-acting Antiviral to Treat HCV Recurrence After Liver Transplantation (ANRSCO23CUPILT) Infection

Who this might be right for
HCV RecurrenceLiver TransplantationDirect-acting Antiviral Agents
ANRS, Emerging Infectious Diseases 699
Large-scale testing (Phase 3)Ended earlyNCT02478229
What this trial is testing

Early Treatment With Sofosbuvir (SOF) and Ledipasvir (LDV) to Prevent HCV Recurrence After Liver Transplantation (OLT)

Who this might be right for
Hepatitis C Viral Infection
University Health Network, Toronto 1
Not applicableStudy completedNCT00170131
What this trial is testing

MMF Influence on HCV Viral Evolution After Liver Transplantation

Who this might be right for
HCV InfectionLiver Transplantation
Mayo Clinic 17
Not applicableStudy completedNCT03665766
What this trial is testing

Effect of Cyclosporine A Versus Tacrolimus on Response to Antiviral Therapy After Hepatitis C Genotype -4 Recurrence Post Liver Transplantation

Who this might be right for
Liver Transplantation
Ain Shams University 126
Not applicableStudy completedNCT00710801
What this trial is testing

Assessment of Biomarkers for Recurrent HCV Infection Post-liver Transplantation

Who this might be right for
Hepatitis C Virus
University of Alberta 40
Not applicableStudy completedNCT02209675
What this trial is testing

Role of Tissue C4d in Differentiation Between Acut e Rejection and HCV Recurrence After Liver Transplantation

Who this might be right for
Liver Disease
Ain Shams University 25
Post-approval studies (Phase 4)Study completedNCT00538265
What this trial is testing

Benefit of Immunoprophylaxis on Fibrosis to Reduce Viral Load After Liver Transplantation

Who this might be right for
Liver Transplantation
University Hospital, Toulouse 100
Not applicableUnknownNCT00213707
What this trial is testing

Study of the Role of Dendritic Cells in the Recurrence of Hepatitis C After Liver Transplantation. Analysis of Hepatitis C Virus (HCV) Quasispecies Evolution.

Who this might be right for
HCV Infection
University Hospital, Strasbourg, France 30
Large-scale testing (Phase 3)Study completedNCT00469131
What this trial is testing

Effects of Immunosuppression on HCV Recurrence After Living Donor Liver Transplantation - Comparative Study Between Tacrolimus + MMF and Tacrolimus + Steroid

Who this might be right for
Hepatitis CLiver Cirrhosis
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan 79
Post-approval studies (Phase 4)Ended earlyNCT03723824
What this trial is testing

Grazoprevir/Elbasvir for Genotype 1b Chronic Hepatitis C After Liver or Kidney Transplantation

Who this might be right for
Chronic Hepatitis cLiver Transplant InfectionKidney Transplant Infection
Taichung Veterans General Hospital 14
Testing effectiveness (Phase 2)Study completedNCT01938625
What this trial is testing

Pharmacokinetics, Efficacy, Safety, Tolerability, of the Combination of Simeprevir (TMC435), Daclatasvir (BMS-790052), and Ribavirin (RBV) in Patients With Recurrent Chronic Hepatitis C Genotype 1b Infection After Orthotopic Liver Transplantation

Who this might be right for
Hepatitis C, Chronic
Janssen R&D Ireland 35
Testing effectiveness (Phase 2)Study completedNCT02010255
What this trial is testing

Ledipasvir/Sofosbuvir Fixed-Dose Combination Plus Ribavirin in Participants With Chronic HCV With Advanced Liver Disease or Post-Liver Transplant

Who this might be right for
Chronic HCV Infection
Gilead Sciences 334
Large-scale testing (Phase 3)Ended earlyNCT00375895
What this trial is testing

Switch From Tacrolimus to Cyclosporin in the Treatment of Recurrent Hepatitis C After Liver Transplantation

Who this might be right for
Chronic Hepatitis CEvidence of Liver Transplantation
Rennes University Hospital 11
Testing effectiveness (Phase 2)Study completedNCT00668369
What this trial is testing

Effect of Immunosuppression Drug Weaning on Hepatitis C Virus (HCV)-Induced Liver Damage After Liver Transplantation

Who this might be right for
Hepatitis C Virus InfectionLiver Transplantation
Hospital Clinic of Barcelona 34
Large-scale testing (Phase 3)Study completedNCT00151580
What this trial is testing

Treatment of Recurrent Hepatitis C After Liver Transplantation

Who this might be right for
Liver TransplantationHepatitis C
Rennes University Hospital 200
Post-approval studies (Phase 4)Ended earlyNCT00260208
What this trial is testing

Liver Fibrosis in Patients Transplanted for Hepatitis C Receiving Either Cyclosporine Microemulsion or Tacrolimus

Who this might be right for
Liver TransplantHepatitis C
Novartis Pharmaceuticals 361
Testing effectiveness (Phase 2)Study completedNCT01938430
What this trial is testing

Ledipasvir/Sofosbuvir Fixed-Dose Combination + Ribavirin in Subjects With Chronic HCV With Advanced Liver Disease or Post-Liver Transplant

Who this might be right for
Chronic HCV Infection
Gilead Sciences 339
Early research (Phase 1)Study completedNCT01074203
What this trial is testing

A Pilot Study to Examine the Role of Nitazoxanide to Prevent Recurrence of Hepatitis C After Transplantation

Who this might be right for
Hepatitis C Recurrence
Mayo Clinic 8
Large-scale testing (Phase 3)Study completedNCT02966795
What this trial is testing

Of Glecaprevir/Pibrentasvir in Adults With Chronic Hepatitis C Virus (HCV) Genotype 5 or 6 Infection

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 84
Testing effectiveness (Phase 2)Study completedNCT00135798
What this trial is testing

Pre-Transplant Treatment to Prevent Recurrence of Hepatitis C After Liver Transplantation

Who this might be right for
Hepatitis C
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 79
Load More Results